Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ALEMTUZUMAB Cause Systemic inflammatory response syndrome? 15 Reports in FDA Database

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

According to the FDA Adverse Event Reporting System (FAERS), 15 reports of Systemic inflammatory response syndrome have been filed in association with ALEMTUZUMAB (Campath). This represents 0.1% of all adverse event reports for ALEMTUZUMAB.

15
Reports of Systemic inflammatory response syndrome with ALEMTUZUMAB
0.1%
of all ALEMTUZUMAB reports
2
Deaths
12
Hospitalizations

How Dangerous Is Systemic inflammatory response syndrome From ALEMTUZUMAB?

Of the 15 reports, 2 (13.3%) resulted in death, 12 (80.0%) required hospitalization, and 1 (6.7%) were considered life-threatening.

Is Systemic inflammatory response syndrome Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ALEMTUZUMAB. However, 15 reports have been filed with the FAERS database.

What Other Side Effects Does ALEMTUZUMAB Cause?

Headache (1,808) Fatigue (1,744) Pyrexia (1,441) Off label use (1,259) Rash (1,094) Nausea (1,053) Dyspnoea (855) Lymphocyte count decreased (852) Asthenia (841) Multiple sclerosis relapse (836)

What Other Drugs Cause Systemic inflammatory response syndrome?

DOXORUBICIN (161) METHOTREXATE (158) CYCLOPHOSPHAMIDE (153) CYTARABINE (153) METHYLPREDNISOLONE (117) ADALIMUMAB (107) RITUXIMAB (106) PREDNISOLONE (99) VINCRISTINE (97) MYCOPHENOLATE MOFETIL (95)

Which ALEMTUZUMAB Alternatives Have Lower Systemic inflammatory response syndrome Risk?

ALEMTUZUMAB vs ALENDRONATE ALEMTUZUMAB vs ALENDRONATE\CHOLECALCIFEROL ALEMTUZUMAB vs ALENDRONIC ACID ALEMTUZUMAB vs ALEVE ALEMTUZUMAB vs ALEVE CAPLET

Related Pages

ALEMTUZUMAB Full Profile All Systemic inflammatory response syndrome Reports All Drugs Causing Systemic inflammatory response syndrome ALEMTUZUMAB Demographics